Madhya Pradesh Deputy Chief Minister Rajendra Shukla has hailed the introduction of advanced immunotherapy at Maharaja Yashwantrao Hospital (MYH) in Indore as a significant milestone in the state’s medical field. According to Shukla, this advancement offers new hope to patients whose conditions have not responded to traditional treatments. This has positioned Indore—and the entire state of Madhya Pradesh—as pioneers in advanced healthcare technologies.
In a landmark move, MYH in Indore has become the first government hospital in India to offer CAR-T (Chimeric Antigen Receptor T-cell) therapy for blood cancer patients. This cutting-edge technology represents a breakthrough for the state’s healthcare infrastructure. The initiative is expected to elevate the reputation of MYH and Madhya Pradesh’s health services on a national scale.
Dr. Ashok Yadav, Superintendent of MY Hospital, shared that CAR-T therapy was developed through a collaborative effort between the Indian Institute of Technology (IIT) Mumbai and Tata Memorial Hospital, two prominent research institutions in India. While this technique remains relatively new in India, around 150 patients have already been treated using CAR-T therapy across various research and healthcare centers. MYH will begin treating its first patient with this advanced therapy on November 20.
Previously, MYH in Indore offered a range of cancer treatments, including chemotherapy, radiation therapy, surgery, and bone marrow transplants. The addition of CAR-T therapy now expands the options available to patients, allowing them to access a broader, more effective range of treatments locally. Immunotherapy, in particular, has shown promise in targeting cancer cells more precisely than conventional therapies, potentially leading to better outcomes for patients with limited treatment options.
This progressive step strengthens Madhya Pradesh’s healthcare capabilities and marks a significant advancement in public hospital services.
